Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 23;31(3):274-280.
doi: 10.1136/ejhpharm-2022-003316.

Standardisation of intravenous infusion therapy for paediatrics: big challenges for the little patients

Irene Taladriz-Sender  1 , Silvia Manrique-Rodríguez  2 , Cecilia M Fernández-Llamazares  1 , Ana Herranz-Alonso  1 , María Sanjurjo-Sáez  1
Affiliations

Standardisation of intravenous infusion therapy for paediatrics: big challenges for the little patients

Irene Taladriz-Sender et al. Eur J Hosp Pharm. .

Abstract

Background: Worldwide organisations advocate standardising the management of intravenous drugs as an essential strategy to increase safety in paediatric healthcare settings. Intravenous administration is a route associated with some potential complications. Many adverse events are related to the use of intravenous medications, and the great variability in their handling and preparation represents an added risk that jeopardises the safety of children.

Purpose: To standardise the dilutions of intravenous drugs most commonly administered to Spanish hospitalised paediatric and neonatal patients.

Methods: The process leading to the standardisation of concentrations was undertaken following a two-round modified Delphi procedure. The consensus included the most common drugs administered by continuous or intermittent intravenous infusion to hospitalised and/or critically ill paediatric patients.

Results: For paediatric patients, the proposal included a total of 102 drugs (45 continuous infusion and 59 intermittent infusion), with 192 concentrations to be standardised. The final consensus included 101 drugs (99%), of which 44 were continuous infusion and 59 intermittent infusion; 160 concentrations were standardised (72.7%). For neonates, the initial proposal included 80 drugs (38 continuous infusion and 43 intermittent infusion), with 189 concentrations to be standardised. The final consensus included 80 drugs (100%), of which 38 were continuous infusion and 43 were intermittent infusion; 120 concentrations were standardised (49.2%).

Conclusions: This proposal showed that standardisation is a feasible approach that can be reached by other healthcare institutions. It can be used in other centres and contribute in the future to unifying paediatric clinical practice.

Keywords: Administration, Intravenous; NEONATOLOGY; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; Safety.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Delphi procedure flow diagram.
See this image and copyright information in PMC

References

    1. World Health Organization . Patient safety monograph, 2019. Available: https://www.who.int/es/news-room/fact-sheets/detail/patient-safety
    1. Aranaz-Andrés JM, Aibar-Remón C, Vitaller-Burillo J, et al. . Impact and preventability of adverse events in Spanish public hospitals: results of the Spanish National Study of Adverse Events (ENEAS). Int J Qual Health Care 2009;21:408–14. 10.1093/intqhc/mzp047 - DOI - PubMed
    1. Ghaleb MA, Barber N, Franklin BD, et al. . Systematic review of medication errors in pediatric patients. Ann Pharmacother 2006;40:1766–76. 10.1345/aph.1G717 - DOI - PubMed
    1. Stockwell DC, Landrigan CP, Toomey SL, et al. . Adverse events in hospitalized pediatric patients. Pediatrics 2018;142:e20173360. 2018. 10.1542/peds.2017-3360 - DOI - PMC - PubMed
    1. Wong ICK, Ghaleb MA, Franklin BD, et al. . Incidence and nature of dosing errors in paediatric medications: a systematic review. Drug Saf 2004;27:661–70. 10.2165/00002018-200427090-00004 - DOI - PubMed

Substances